Risk factors for venous thrombosis in patients with endoprosthetics of hip joints
Keywordsthromboembolism, endoprosthetics, dysplasia
Background. Important part of orthopaedic surgery is endoprosthetics of hip joints, which eliminates pain syndrome, restores the amplitude of movements and the support ability of the lower limb. But there is a number of complications; venous thromboembolism among them occupies a leading place.
Material and methods. 219 patients with a mean age of 64.7 ± 3.8 years were operated. In 137 (62.1%) observations, total cement hip replacement was performed for osteoarthritis. 82 (37.4%) patients received total and unipolar cement hip replacement for cervical femoral neck fractures.
Results. Clinical manifestations of non-specific connective tissue dysplasia were detected in 83 (37.9%) patients, which were confirmed by the laboratory determination of the level of general, bound and free oxyproline. In the postoperative period, the thrombotic process in the venous system of the inferior vena cava was diagnosed in 23 (10.5%) observations. Operative intervention on the hip joint in patients with nonspecific dysplasia of connective tissue in 11 (13.3%) cases was complicated by the development of venous thrombosis. In patients without non-specific connective tissue dysplasia, postoperative thrombosis in the system of the inferior vena cava was diagnosed in 12 (8.8%) observations.
Conclusions. Patients with osteoarthrosis of the hip joint and the femoral neck fracture accompanied by the non-specific dysplasia of the connective tissue are characterized by expressed levels of endothelial dysfunction and increased activity of the blood-coagulation system.
Loskutova AE. Endoprotezirovanie tazobedrennogo sustava: Monografiya. D:Lira.2010:1-344.
Geerts WH, Bergavist D, Pineo GF, Heit JA, Samama CM, Lossen MR, Colwell CW. Prevention of Venous Tromboembolism: Evidence – Based Clinical Physicians (8 Editions). J Chest. 2008;133: 381- 453.
Yasunaga H, Tsuchiya K, Matsuyama Y, Ohe K. High – volume surgeons in regard to reductions in operations time, blood loss, and postoperative complications for total hiparthroplasty. Orthop Sci. 2009;14(1):3-9.
Eriksson BI, Borrs LC, Friedman RJ et al. Riwaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. Engl J Med. 2008;358(26):2765 – 2775.
Haas SB, Barrack RL, Westrich G. Venous tromboembolic disease after total hip and knee arthroplasty. Inter Course Lect. 2009;58:781 – 93.
Venher I. Non-specific connective tissue dysplasia – a risk factor for postoperative thrombosis in the venous system of lower extremities. Health problems of Cicilization. 2016;10: 51 – 4.
Ginsberg JS, Davidson BL, Comp PC, Francis CW, Fridman RJ et al. Oral thrombin inhibitor dabigatran etaxilateus North American enoxaparin regimen for prevention of venous thromboemlism after knee arthroplasty surgery. J Arthroplasty. 2016;24:1-9.
Venher IK, Rusin VI, Kostiv SY, Zarudna OI, Kostiv OI. Hypercoagulable syndrome in the early postoperative period is a factor of venous thromboembolism. Novosti Khirurgii. 2017:267 – 72.
Kuchin YuL, Glumcher FS, Stashkevich VS, Tarasenko SO. Vpliv pochatku tromboprofIlaktiki na chastotu gemoragIchnih ta trombotichnih uskladnen u hvorih z travmoyu. J Travma.2013;14(2):53 – 8.
Kostiv SYa.Tromboprofilaktika pri operativnomu vtruchanni u patsientiv iz visokim rizikom rozvitku tromboembolichnih uskladnen. Naukoviy visnik Uzhgorodskogo Universitetu, seriya «Meditsina». 2014;1(49);112 –4.
Arbit E, Goldberg M, Gomez-Orellana I, Majuru J. Oral heparin: status review. Tromb J. 2006;1:4 – 6.
How to Cite
Copyright (c) 2021 Ihor Venher, Sviatoslav Kostiv, Dymytrii Khvalyboha
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 126
Number of citations: 0